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Knockdown High mobility nucleosomal binding 
proteins 2 (HMGN2) alter the histone 
modification H4K4me3 and H3K27me3 and 
regulates stem cells pluripotency. 
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Western blot data from two different experiments indicate a reduction in
the expression of Hmgn1 and Hmgn2 after neural induction. Both proteins
are found at high levels in undifferentiated ECCs, and are nearly
undetectable in terminal stages of differentiation. The Hmgn2 mRNA
levels are consistent with the western blot results, decreasing during the
differentiation process. However, Hmgn1 mRNA seems to be fluctuating
through the different time points analyzed.
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Knockdown of Hmgn2 using a lentiviral
system (pGIPZ) in P19 cell lines
HMGN2
Data from the Allen Brain Atlas indicates that Hmgn1
and Hmgn2 mRNAs are highly expressed in active
neurogenic regions of the developing and adult mouse
brain, including the subventricular zone and the
dentate gyrus of the hippocampus.
P19 cells were transduced with lentiviruses expressing three 
different shRNAmir triggers against Hmgn2 or a control. 
Cells were selected with puromycin, and FACS analysis 
shows the percentage of positive transduced cells. 
Transduced cells express GFP
Fluorescent microscopy on 
day 20 for P19 cells 
transduced with the 381 
shRNAmiR trigger against 
Hmgn2.  
Gene expression data from transduced cells, 20 days after 
transduction. The data show a knockdown in HMGN2 levels, no 
change in HMGN3, and an increase in HMGN1. 
Consistent with the data from siRNA transfections, HMGN2
knockdown was associated with reductions in Nanog and Oct4
expression. However, Sox2 expression was increased in the
lentiviral experiment rather than decreased.
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Adherent monolayer culture efficiently drives 
production of  NPCs and neurons from P19 ECs
siRNA knockdown of Hmgn1 or Hmgn2
reduces the expression of pluripotency 
markers in pluripotent P19 EC cells.
PCR array analyses reveal that several markers of early 
differentiation are upregulated in Hmgn-knockdown  EC cells. The 
expression of several genes required for ES self renewal and 
pluripotency is also disrupted.
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Pluripotency gene expression is 
altered in Hmgn2 knockdown cells
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Introduction
High mobility group nucleosome binding proteins 
(HMGN) are ubiquitous non-histone chromosomal 
proteins. They play important roles in regulating 
chromatin architecture and transcription. There are 
five family members: Hmgn1, Hmgn2, Hmgn3a/b, 
Hmgn4 and Hmgn5. 
Hmgn1 and Hmgn2 expression is reduced during 
neuronal differentiation in vitro 
HMGN proteins bind to nucleosomes with their 
highly conserved nucleosome binding domain 
(NBD). The C-terminal regulatory domain (RD) 
modulates specific histone modifications and disrupts 
the binding of linker histones (H1) to chromatin. 
Several studies have shown that HMGN1 and 
HMGN2 are highly expressed in tissue-specific 
progenitor and transit-amplifying cells, and are down-
regulated in terminally differentiated cells. Functional 
studies have shown that they play important roles in 
several cellular differentiation pathways, including 
erythropoiesis, myogenesis, osteoblast differentiation.
Consistent with the expression pattern data, a previous 
study1 has shown that Hmgn1 is important for regulating the 
differentiation of neural stem cells, both in vitro and in vivo. 
Our immediate aim is to develop an in vitro model system 
with which to investigate the role of HMGN proteins and 
epigenetic processes during neuronal differentiation. Here, 
using an adherent culture system2, we demonstrate that the 
expression of HMGN1 and HMGN2 proteins decreases 
during the terminal differentiation of neurons from P19 
embryonic carcinoma cells.
1 Nagao et al (2014) Stem cells 32(11):2983-97
2 Nakayama et al (2014) Journal of Neuroscience Methods. 
227; 100–106.
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In order to verify the results from the transient siRNA 
experiments, HMGN2 was knocked down using shRNAmiR
expressed from lentiviral vectors.
HMGN2 KD cells show reductions in 
Oct4 and Nanog expression
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Consistent with the data from qRT-
PCR and western blotting of whole 
cell extracts, reductions in Hmgn2, 
Oct4 and Nanog were observed in 
chromatin from cells transduced 
with the 318 trigger. 
Notably, Sox2 and c-Myc were 
also downregulated, whereas Klf4 
was upregulated. 
A slower migrating form of TBP 
was observed in the 318 
knockdown cells
In order to study the levels of histone modifications and DNA 
bound factors, chromatin was prepared from transduced cells. 
After reversing the crosslinks, samples were run on SDS-PAGE 
and analysed by western blotting.
We have presented data from two independent approaches 
indicating that Hmgn2 plays a role in regulating key pluripotency 
genes such as Oct4, Nanog and c-Myc in mouse embryonal 
carcinoma cells.
Moreover we found that the loss of Hmgn2  compensate with the 
Hmgn1 at the same location in mRNA , western blot and ChIP-
QPCR analysis. 
Enhancer is marked by Histone post translational modification 
(H3K4me3). this indicate that Hmgn2 may affect the enhancer 
region at the active genes. 
Work is currently ongoing to investigate whether Hmgn2 
regulates expression of pluripotency genes in mouse ES cells as 
well as in EC cells. 
Hmgn2 binds at the enhancer of active genes   
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Western blotting of whole cell extracts confirms Hmgn2 
knockdown and loss of Nanog and Oct4 expression. 
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Hmgn1 and Hmgn2 regulate gene 
expression in day 3 neuronal cells
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* P < 0.05
Gene expression data from Hmgn1 and Hmgn2 knockdown after neuronal
indication on day 3. these genes are not expressed in undifferentiated P19
EC cells. interestingly, GlyT2 expression is highest on day 3 of neural
differentiation. HMGN2 knockdown during neural differentiation reduced
GlyT2 expression by 75%, whereas the HMGN1 knockdown reduced
GlyT2 expression by about 40% compared to wild type cells. In contrast,
there was a trend towards increased expression of GlyT1a in the HMGN1
and HMGN2 single knockdowns. The expression of Zfp521 is down-
regulated upon HMGN1 and HMGN2 knockdown .
1   2   3          
Hmgn2
Hmgn1
Nanog
Oct4
sox2
Actin
1. WT P19
2. NON-SILENCING
3. shRNA 381
 1     2       3     4       5      6
1. WT P19
2. Mouse ES cells
3. 381 (Hmgn2 trigger)
4. Non-silencing trigger
1  2   3  4   5      6
DNA gel
1 2 3 4
500 bp
ChIP-qPCR analysis in Hmgn2
knockdown cells 
1    2   3 4
c-Myc
Klf4
Sox2
Oct4
TBP
Hmgn1
Hmgn2
Nanog
0
1
2
3
4
5
6
7
8
OCT1. OCT2. OCT3. OCT4. OCT5. ACTIN MSAT
H
m
gn
2
 r
e
la
ti
ve
 e
n
ri
ch
m
e
n
t 
oct4 promoter sites 
NON-SILENCING
shHMGN2-381
0
1
2
3
4
5
6
N1 N2 N3 N4 N5 ACTIN MSAT
H
m
g
n
2
 r
e
la
ti
v
e
 e
n
ri
ch
m
e
n
t 
Nanog promoter sites 
Non-silencing
shHMGN2-381
0
1
2
3
4
5
6
7
8
9
OCT1. OCT2. OCT3. OCT4. OCT5. ACTIN MSAT
H
m
gn
1
 r
e
la
ti
ve
 e
n
ri
ch
m
e
n
t 
oct4 promoter sites 
non-silencing
shHMGN2-381
0
1
2
3
4
5
6
7
8
9
N1 N2 N3 N4 N5 ACTIN MSAT
H
m
gn
1
 r
e
la
ti
ve
 e
n
ri
ch
m
e
n
t 
Nanog prmoters 
Non-silencing
shHMGN2-381
QPCR analysis of Oct4 and Nanog around transcription stating sites
(TSS) after Hmgn1 and Hmgn2 ChIP. Global loss of Hmgn2 and
enrichment of Hmgn1 around Oct4 and Nanog TSS in Hmgn2
knockdown P19 EC cells.
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Repression of Oct4 and Nanog in Hmgn2 knockdown cells is 
accompanied by increases in the repressive mark H3K27me3
Repression of Oct4 and Nanog in Hmgn2 knockdown cells is 
accompanied by a reduction in the active mark H3K4me3
Schematic representation of the main chromatin structural
elements of enhancers (Martinez de Paz and Ausio, 2015)
